Home » Newsletters » BioWorld

BioWorld

July 10, 2006

View Archived Issues

Replidyne Lowers Shares, Price, Raises $45M In IPO

It's a familiar story these days: Companies file for initial public offerings with high hopes but usually settle for less. (BioWorld Today) Read More

Locus Entering Development Agreement With Japan's Ono

Sonus Bolsters Paclitaxel Bid With Buy Of Phase III Results

Novozymes Getting Protein Production, More From Delta

Other News To Note